BioLife Solutions, Inc. (BLFS) Free cash flow 2016–2025
BioLife Solutions, Inc. (BLFS) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$10.6MFY2025 · since FY2016: -$4.5M → $10.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $10.6M | +104.4% |
| FY2024 | $5.2M | +127.6% |
| FY2023 | -$18.9M | -0.0% |
| FY2022 | -$18.9M | -45.4% |
| FY2021 | -$13.0M | -377.1% |
| FY2020 | $4.7M | +770.6% |
| FY2019 | $538,000 | -70.9% |
| FY2018 | $1.8M | +300.9% |
| FY2017 | $461,000 | +110.3% |
| FY2016 | -$4.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More BLFS financial trends
BLFS RevenueBLFS Net incomeBLFS Net marginBLFS Gross profitBLFS Gross marginBLFS Operating incomeBLFS Operating marginBLFS Operating cash flowBLFS Capital expendituresBLFS Return on equityBLFS Stock buybacksBLFS Dividends paidBLFS Total assetsBLFS Total liabilitiesBLFS Shareholders’ equityBLFS overview →